Pharmacoeconomics 2008; 26 (9): 733-744
نویسندگان
چکیده
1 Academic Unit of Health Economics and NICE Decision Support Unit, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK 2 Centre for Health Economics, Department of Economics and NICE Decision Support Unit, University of York, Heslington, York, UK 3 Centre for Health Economics, Department of Economics, University of York, Heslington, York, UK 4 Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
منابع مشابه
Rules of Conduct and Principles of Adjudication
I. Rules of Conduct and Principles of Adjudication: The Distinction and Its Implications .............. 730 II. Rules of Conduct and Principles of Adjudication in Current Doctrine ................................ 733 A. The Distinction Applied to Current Doctrine.. 733 1. Objective elements of an offense .......... 733 2. Secondary prohibitions .................. 734 3. State of mind elements ....
متن کاملPharmacoeconomics 2008; 26 (9): 769-779
This article reviews the general issues in valuing health states for use in costAbstract effectiveness analysis and the specific issues considered by the National Institute for Health and Clinical Excellence (NICE) in its recent review of the methods of technology appraisal. The general issues are how to describe health, how to value health and who should provide the values for health. The spec...
متن کاملPharmacoeconomics 2008; 26 (1): 75-90
Background: Invasive fungal infections in neutropenic patients treated for
متن کاملMicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma
MicroRNA controls cancer invasion by governing the expression of gene regulating migration and invasion. Here, we reported a novel regulatory pathway controlled by miR-744-3p, which enhanced expression of matrix metallopeptidase 9 (MMP-9) in laryngeal squamous cell carcinoma (LSCC). We profiled the differential micoRNA expression pattern in LSCC cell lines and normal epithelial cultures derived...
متن کاملGSK1265744 pharmacokinetics in plasma and tissue after single-dose long-acting injectable administration in healthy subjects.
BACKGROUND GSK1265744 (744) is an HIV-1 integrase inhibitor in clinical development as a long-acting (LA) injectable formulation. This study evaluated plasma and tissue pharmacokinetics after single-dose administration of 744 LA administered by intramuscular (IM) or subcutaneous injections. METHODS This was a phase I, open-label, 9-cohort, parallel study of 744 in healthy subjects. 744 was ad...
متن کامل